Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Dna X (SONM) Other Gross PP&E Adjustments (2018 - 2025)

Dna X filings provide 8 years of Other Gross PP&E Adjustments readings, the most recent being -$110000.0 for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 117.92% to -$110000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$110000.0, a 117.92% decrease, with the full-year FY2025 number at -$110000.0, down 117.92% from a year prior.
  • Other Gross PP&E Adjustments hit -$110000.0 in Q4 2025 for Dna X, down from $614000.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $5.3 million in Q4 2021 to a low of -$956000.0 in Q2 2022.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$321000.0 (2023), compared with a mean of $246545.5.
  • Biggest five-year swings in Other Gross PP&E Adjustments: surged 6971.43% in 2023 and later tumbled 117.92% in 2025.
  • Dna X's Other Gross PP&E Adjustments stood at $5.3 million in 2021, then tumbled by 100.13% to -$7000.0 in 2022, then surged by 6971.43% to $481000.0 in 2023, then increased by 27.65% to $614000.0 in 2024, then tumbled by 117.92% to -$110000.0 in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were -$110000.0 (Q4 2025), $614000.0 (Q4 2024), and $481000.0 (Q4 2023) per Business Quant data.